Form D - Notice of Exempt Offering of Securities:
SEC Accession No. 0001062993-14-001876
Filing Date
2014-04-02
Accepted
2014-04-01 20:17:03
Documents
1
Effectiveness Date
2014-04-02
Items
Item 06b:

Document Format Files

Seq Description Document Type Size
1 primary_doc.html D  
1 primary_doc.xml D 6764
  Complete submission text file 0001062993-14-001876.txt   8027
Mailing Address 51 W 52ND STREET, 7TH FLOOR NEW YORK NY 10019-6163
Business Address 51 W 52ND STREET, 7TH FLOOR NEW YORK NY 10019-6163 800-689-3939
ANAVEX LIFE SCIENCES CORP. (Filer) CIK: 0001314052 (see all company filings)

EIN.: 208365999 | State of Incorp.: NV | Fiscal Year End: 0930
Type: D | Act: 33 | File No.: 021-214701 | Film No.: 14735892
SIC: 8731 Services-Commercial Physical & Biological Research